BMO Capital analyst Kostas Biliouris downgrades Precision BioSciences (NASDAQ:DTIL) from Outperform to Market Perform and lowers the price target from $7 to $4.
JP Morgan analyst Jeremy Tonet downgrades Crestwood Equity Partners (NYSE:CEQP) from Overweight to Neutral and lowers the price target from $31 to $28.
CNBC “Mad Money” host Jim Cramer mulled over the potential outcome of the abysmal sell-off in the regional banks in the wake of the collapse of the Silicon Valley Bank owned by SVB Financial Group (NASDAQ: